-
Markten
athexgroup.grAthens Exchange GroupLees meerTogether for a unified, stronger European capital market.
-
Aandelen
Sustainable finance2025 Euronext ESG Trends ReportLees meerA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLees meerThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeLees meerInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondsen
-
Obligaties
European Defence BondsGroupe BPCE lists the first bondLees meerFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Gestructureerde producten
-
Derivaten
Where European Government Bonds Meet the FutureFixed Income derivativesLees meerTrade mini bond futures on main European government bonds
-
Commodities
- Overzicht
- Agricultural quotes
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Container Freight Futures
- Levering en afwikkeling
- Specificaties en regelingen
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLees meerEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Meer
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLees meerJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 30 May 2025 07:00 CEST |
Lifecare ASA | Lifecare announces second clinical trial site at Pfützner Science & Health Institute in Mainz, Germany | 20103010 Biotechnology | Non-regulatory press releases |
| 27 May 2025 07:00 CEST |
Lifecare ASA | Lifecare appoints renowned metabolic expert Prof. Simon Dankel as Principal Investigator for upcoming clinical trial | 20103010 Biotechnology | Non-regulatory press releases |
| 20 May 2025 07:00 CEST |
Lifecare ASA | Lifecare files for human clinical trial, paving the way for CE-mark | 20103010 Biotechnology | Non-regulatory press releases |
| 16 May 2025 14:01 CEST |
Lifecare ASA | Lifecare ASA: Livestream strategic update | 20103010 Biotechnology | Non-regulatory press releases |
| 15 May 2025 07:00 CEST |
Lifecare ASA | LIFE: Lifecare ASA Q1 2025 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 09 May 2025 07:00 CEST |
Lifecare ASA | Lifecare ASA (LIFE): Invitation to presentation of Q1 2025 results and strategic update | 20103010 Biotechnology | Non-regulatory press releases |
| 24 Apr 2025 17:30 CEST |
Lifecare ASA | Minutes from Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Apr 2025 07:00 CEST |
Lifecare ASA | Lifecare ASA: Updated company presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Apr 2025 13:25 CEST |
Lifecare ASA | Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Mar 2025 07:00 CET |
Lifecare ASA | Lifecare ASA Annual Report 2024 | 20103010 Biotechnology | Annual financial and audit Reports |
| 25 Mar 2025 09:16 CET |
Lifecare ASA | LIFE: First positive indication of increased sensor sensitivity in ongoing longevity study | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Mar 2025 07:00 CET |
LIFECARE ASA | Lifecare scientific updates: CGM symposium in Bergen, consensus recommendations from the Diabetes Technology Society and presentation of data at ATTD 2025 | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Feb 2025 07:00 CET |
LIFECARE ASA | LIFE: Lifecare ASA Q4 2024 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 14 Feb 2025 09:24 CET |
LIFECARE ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Feb 2025 07:00 CET |
LIFECARE ASA | LIFE: Improved chemistry successfully tested in sensor | 20103010 Biotechnology | Non-regulatory press releases |
| 16 Jan 2025 09:49 CET |
LIFECARE ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Jan 2025 07:00 CET |
LIFECARE ASA | LIFE Fivefold improvement of sensor chemistry sensitivity | 20103010 Biotechnology | Non-regulatory press releases |
| 13 Nov 2024 07:00 CET |
LIFECARE ASA | LIFE: Lifecare ASA Q3 2024 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 05 Nov 2024 10:40 CET |
LIFECARE ASA | Lifecare ASA Q3 2024 presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 29 Oct 2024 07:00 CET |
LIFECARE ASA | Lifecare - Sanofi Product Development Agreement Update | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Oct 2024 10:00 CEST |
LIFECARE ASA | Lifecare ASA listed on Euronext Oslo Børs | 20103010 Biotechnology | Non-regulatory press releases |
| 21 Oct 2024 17:27 CEST |
LIFECARE ASA | LIFE Lifecare ASA uplisting to Euronext Oslo Børs is approved | 20103010 Biotechnology | Non-regulatory press releases |
| 18 Oct 2024 10:59 CEST |
LIFECARE ASA | Lifecare ASA: Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 15 Oct 2024 23:05 CEST |
LIFECARE ASA | Lifecare ASA: Public retail offering successfully placed | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Last day of application period | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Oct 2024 07:05 CEST |
LIFECARE ASA | Lifecare presentation at the Diabetes Technology Meeting 2024. | 20103010 Biotechnology | Non-regulatory press releases |
| 14 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Application deadline for applicants using Nordnet webservice | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 Oct 2024 15:10 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Oct 2024 07:00 CEST |
LIFECARE ASA | LIFE Study protocol has been finalized for submission to regulatory authorities | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Oct 2024 07:05 CEST |
LIFECARE ASA | LIFE Longevity trial: Biopsy and bacteriological examination confirm no unexpected foreign body reactions after removal of implant | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Launch of public retail offering and commencement of application period | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Oct 2024 11:42 CEST |
LIFECARE ASA | Lifecare ASA: Approval and publication of prospectus | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Oct 2024 08:24 CEST |
LIFECARE ASA | OSLO BØRS – TRADING RESUMPTION WARRANTS | 20103010 Biotechnology | Trading halts |
| 02 Oct 2024 20:57 CEST |
LIFECARE ASA | Lifecare ASA: Announcement of terms of public retail offering | 20103010 Biotechnology | Inside information |
| 02 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA First successful production based on automatization of critical processes | 20103010 Biotechnology | Non-regulatory press releases |
| 01 Oct 2024 08:39 CEST |
LIFECARE ASA | OSLO BØRS – TRADING SUSPENSION WARRANTS | 20103010 Biotechnology | Trading halts |
| 01 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Ex. consolidation (reverse split) of shares and warrants today | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Sep 2024 17:31 CEST |
LIFECARE ASA | Lifecare ASA: Share consolidation (reverse split) and change of par value | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Sep 2024 17:22 CEST |
LIFECARE ASA | Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants and change of ISIN for the shares | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Sep 2024 15:14 CEST |
LIFECARE ASA | Euronext Oslo Børs – Decision on admission to trading – Lifecare ASA | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Sep 2024 15:14 CEST |
LIFECARE ASA | Euronext Oslo Børs – Vedtak om opptak til handel – Lifecare ASA | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 26 Sep 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Sep 2024 12:15 CEST |
LIFECARE ASA | Lifecare ASA: Re-purchase of shares and warrants completed | 20103010 Biotechnology | Acquisition or disposal of the issuer’s own shares |
| 25 Sep 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Re-purchase of shares and warrants | 20103010 Biotechnology | Acquisition or disposal of the issuer’s own shares |
| 17 Sep 2024 11:00 CEST |
LIFECARE ASA | Minutes from Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Sep 2024 07:00 CEST |
LIFECARE ASA | LIFE Successfully completes the first patient in the longevity trial after three months | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Sep 2024 14:31 CEST |
LIFECARE ASA | LIFECARE ASA: Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Aug 2024 16:18 CEST |
LIFECARE ASA | Euronext Oslo Børs - Received application for admission to trading – Lifecare ASA | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Aug 2024 16:18 CEST |
LIFECARE ASA | Euronext Oslo Børs - Mottatt søknad om opptak til handel – Lifecare ASA | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 30 Aug 2024 15:50 CEST |
LIFECARE ASA | Correction: LIFE: Lifecare ASA Q2 2024 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |